India and Taiwan Roll Out Domestically Produced COVID Vaccines Despite Lack of Trial Data

HeadlineAug 23, 2021

India has authorized emergency use of another Indian-made COVID-19 vaccine, after its producer said it prevented symptomatic infections in two-thirds of recipients. Regulators approved ZyCoV-D even though there’s no publicly available data on its performance in advanced clinical trials.

In Taiwan, President Tsai Ing-wen has publicly received a shot of the home-grown Medigen vaccine. Regulators approved the two-dose vaccine last July — though a late-stage clinical trial remains ongoing.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.

Non-commercial news needs your support

We rely on contributions from our viewers and listeners to do our work.
Please do your part today.
Make a donation